This site is intended only for all Healthcare Professionals residing in South Africa




Sign InLog Out Our medicinesTherapy areasExplore contentExplore contentEventsDownloadable materialsVideosLet’s connectLet's ConnectContact usPfizer medical information



About ZINFORO Clinical efficacy Dosing and administration Package Insert Safety and tolerability The ZINFORO® patient Support & Resources
Zinforo® HomeClinical InformationSupport & Services

There are no support items available.

For high-risk patients with CABP and ABSSSI
Learn more about ZINFORO® Loading
See efficacy results Loading
See safety profile Loading
View dosing recommendations
Read moreLoading


ABSSSI, Acute Bacterial Skin and Skin Structure; CABP, Community-Acquired Bacterial Pneumonia


  1. ZINFORO® 600mg (Powder for concentrate for solution for infusion).South African approved package insert.13 May 2019
  2. Metlay JP, et al. Am J Respir Crit Care Med 2019;200:e45–67;
  3. Stevens DL, et al. Clin Infect Dis 2014;59:147–59; 
  4. Rosanova MT, et al. Ther Adv Infect Dis 2019;6:1–13;
  5.  Friedland HD, et al. Antimicrob Agents Chemother 2012;56:2231–36;
  6. Eckburg PB, et al Infect Dis Clin Pract 2012;20:254–60.
  7. Laudano JB. Ceftaroline fosamil: a new broad-spectrumcephalosporin. J Antimicrob Chemother. 2011;66 Suppl 3:iii11-iii18.

Copyright ©2023 Pfizer South Africa All rights reserved.

  • The information contained herein is provided for educational purposes only and is not intended to constitute medical advice or replace discussions with a Healthcare Professional. All decisions regarding patient care must be made with a Healthcare Professional, considering the unique characteristics of the patient.
  • While every effort is made to update the information regularly and to offer the most current, correct and clearly expressed information possible, Pfizer cannot be held responsible for any inaccuracy, errors, omissions or misinterpretations.
  • Pfizer, its officers and/or its employees do not accept or take any responsibility whatsoever for any loss, whether direct, indirect or consequential, which may arise from reliance on information contained on these pages and actions resulting therefrom. Any liability that would or could arise as a result of the contents of these pages is hereby excluded to the fullest extent allowed by law.
  • No warranty is given that any files, downloads or applications available via this web site are free of viruses which have the ability to corrupt your system.
  • Any and all information is subject to change without notice.
  • The information provided in this site is intended only for appropriate Healthcare Professionals residing in South Africa.


PfizerPro AccountPfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign inRegisterAccountSign Out

This site is intended only for all Healthcare Professionals residing in South Africa. If you are a member of the public wishing to access information on a specific medicine, please visit


This website is brought to you by Pfizer South Africa 

Pfizer Laboratories (Pty) Ltd. Company Reg. No. 1954/000781/07. Building 2, 1st Floor, Maxwell Office Park, Magwa Crescent, Waterfall City, Midrand, Johannesburg, South Africa. Tel. No: 0860 PFIZER (734937).


Copyright © 2023. Pfizer Laboratories (Pty) Ltd. All rights reserved

For South Africa Healthcare Professionals *

These pages are not intended for patients or for members of the general public. The healthcare professional webpages contain promotional content.

I confirm that I am a healthcare professional residing in South Africa. If you select 'No', you will be redirected to where you will be able to access reference information on Pfizer's prescription medicines.

Yes No
You are now leaving the PfizerPro South Africa website
You are leaving the South Africa HCP Portal website and being directed to a new website

This website is not controlled by South Africa HCP portal or subject to our privacy policy.

Thank you for visiting our site. We hope your visit was informative and enjoyable